Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.
Japanese Journal of Clinical Oncology
|
February 1, 2005
Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
In Sil Choi, Do-Youn Oh, Jung Hye Kwon, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
Changhee Park, Koung Jin Suh, Se Hyun Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2015
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Ki Hyeong Lee, Ji-Yeon Kim, Moon Hee Lee, et al.
Cancer Research and Treatment
|
April 2, 2016
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Se Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, et al.
Cytokine
|
March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)
Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2025
Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancer
Seung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2022
Oxaliplatin (3 months <i>v</i> 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
Seung Tae Kim, Sun Young Kim, Jeeyun Lee, et al.
Anticancer Research
|
December 30, 2023
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
Jwa Hoon Kim, Yongjun Cha, Sang Joon Shin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 10, 2017
Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients
So Yeon Oh, Sang Won Shin, Su-Jin Koh, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
European Journal of Cancer (Oxford, England : 1990)
|
October 27, 2023
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.
Japanese Journal of Clinical Oncology
|
February 1, 2005
Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer
In Sil Choi, Do-Youn Oh, Jung Hye Kwon, et al.
Cancer Immunology, Immunotherapy : CII
|
August 6, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer
Changhee Park, Koung Jin Suh, Se Hyun Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2015
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Ki Hyeong Lee, Ji-Yeon Kim, Moon Hee Lee, et al.
Cancer Research and Treatment
|
April 2, 2016
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Se Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, et al.
Cytokine
|
March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)
Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2025
Proliferation of tumor-related regulatory T cells in circulation dictates efficacy of chemoimmunotherapy in triple-negative breast cancer
Seung Hyuck Jeon, Koung Jin Suh, Sungmin Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2022
Oxaliplatin (3 months <i>v</i> 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
Seung Tae Kim, Sun Young Kim, Jeeyun Lee, et al.
Anticancer Research
|
December 30, 2023
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study
Jwa Hoon Kim, Yongjun Cha, Sang Joon Shin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 10, 2017
Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients
So Yeon Oh, Sang Won Shin, Su-Jin Koh, et al.
Page
of 7